Introduction {#Sec1}
============

The global socioeconomic development generates a stream of substances (some of them are new), which almost immediately occur in the environment. It has been estimated, that the chemical industry currently produces more than 70 000 different chemical products, with an estimated worldwide sales value of \$5000 billion (Asthana [@CR5]). Many of these substances released into the aquatic environment pose a serious risk for the environment and for human health.

In the last decade, the political awareness of water quality issues has grown substantially in the European Union (EU), as wastewater treatment plants (WWTPs) have been identified as a major point source pollution (Corominas et al. [@CR11]). Conventional WWTPs are incapable of eliminating many compounds found in wastewater. In last decades, much attention has been paid to analytics compounds such as endocrine-disrupting chemicals (EDCs) or pharmaceuticals. Treated wastewater released from WWTPs can be discharged to the receiving bodies such as surface waters (e.g., rivers, lakes) or, preferably from the end of the last century in some regions, sea waters. As a consequence, many compounds found in wastewater effluents and/or their metabolites and transformation products are detected in surface waters and to great concern of scientists, end up in marine environment. The properties of these substances and their impact on the environment and human health are often unknown. Knowledge about the long-term effects of exposure to a mixture of pollutants present in the environment at low concentration levels is still limited (HELCOM [@CR37]). It should be noted that only substances that are commonly found in the environment at a significant concentration levels and at the same time posing a threat to the environment and/or human health are covered by legal norms (compounds regulated by law). For example, according to Art. 16 of the Water Framework Directive is the list of priority substances that pose a threat to the aquatic environment. This risk is assessed according to a procedure based on scientific principles. To include the substance in the list of priority substances in the field of water policy, a reliable scientific evidence must be provided '*regarding the intrinsic hazard of the substance concerned, and in particular its aquatic ecotoxicity and human toxicity* via *aquatic exposure routes, and evidence from monitoring of widespread environmental contamination, and other proven factors which may indicate the possibility of widespread environmental contamination, such as production or use volume of the substance concerned, and use patterns*' (WFD [@CR91]). Therefore, only a small number of compounds is covered by the legal regulations (Fig. [1](#Fig1){ref-type="fig"}). These compounds are systematically monitored in the environment, e.g., polychlorinated biphenyls (PCBs). But large number of compounds and their degradation products fall outside of any control. Among the non-regulated by law compounds, compounds which can be expected in the wastewater due to their considerable emission into the environment can be distinguished. Currently, these are mostly pharmaceuticals. The second and most numerous group constitutes unknown compounds. The number of potential contaminants is essentially endless. For example, over 10 000 prescription drugs and about 300 over-the-counter drugs are currently in use and produced in USA and may be released to the environment during processing or use (Dong et al. [@CR19]). Furthermore, degradation and transformation products of certain substances in the environment can have unknown structure and properties. The newly formed, emerging, products may pose a greater threat to the environment (and organisms living in it) than the parent compounds (Garnaga [@CR26]). It should also be noted that in an aquatic environment, substances are present in the mixtures and still there is a lack of comprehensive knowledge about the effects of chemicals, their combinations/mixtures on the environment and human health.Fig. 1Types of compounds found in the aquatic environment

The aim of our study was to review literature on the presence of contaminants in treated sewage and their highest concentrations. We point out that the research articles on the pollutants present in wastewater are primarily based on target analysis. On the other hand, there are very few research papers covering problems related to identification of non-target compounds in treated effluents. What is more, we have indicated threats to aquatic ecosystems as a consequence of the presence of toxic compounds and endocrine active compounds in treated effluents on the basis of ecotoxicological studies. The information has been supplemented with legal issues linked to contamination of treated wastewater and research (and problems) related to identification of non-target compounds in wastewater effluents.

Methods {#Sec2}
=======

In this review, we have focused on recent studies published from years 2015--2019. We searched Scopus database, which provides access to STM journal articles and the references included in those articles. We entered a combination of terms/keywords such as 'micropollutants,' 'concentration,' 'effluents,' and 'wastewater' into search box and sorted results by relevance. In literature, we were looking for the highest measured and reported concentrations of compounds in effluents from conventional wastewater treatment plants worldwide, collecting a mixture of domestic and industrial wastewater. In our review, we do not include concentrations of compounds found in effluents coming from industry alone (e.g., pharmacy, slaughter house, pulp and paper, textiles, hospital effluents), wastewater influents, potable water, surface waters. Due to the fact that for each year we found over 600 references and the resources are virtually infinite, the present review is a selection of just some of the major studies. Our selection of micropollutants thus must focus on chemicals that in our opinion pose the greatest threat to environment is due to the following: high measured concentrations, significant ecotoxicity, frequency of detection, and unsatisfactory removal efficiency. For the micropollutants with the highest concentrations detected, we compiled ecotoxicity data based on laboratory results.

The occurrence of micropollutants in wastewaters was revised by many authors: Das et al. ([@CR13]), Jiang et al. ([@CR46]), Luo et al. ([@CR57]), Petrie et al. ([@CR66]), and Ratola et al. ([@CR72]). These reviews mainly indicate compounds detected in treated wastewaters, and efficacy and methods of wastewater treatment. Therefore, in our review we decided to fill in the knowledge gap and added ecotoxicity data for the micropollutants with the highest measured concentrations mentioned in literature.

Micropollutants in treated wastewater {#Sec3}
=====================================

Legal aspects of contaminants in treated wastewater {#Sec4}
---------------------------------------------------

In Europe, the state of the aquatic environment is controlled by legislation outlined by the European Commission. Directive 2000/60/EC setting out the framework for community action in the field of water policy has reformed the water quality policy of the community, and is the first attempt to move towards ecosystem-based management that should ensure the good ecological status (WFD [@CR91]; Corominas et al. [@CR11]). Its aim is the prevention of water pollution within the European Union through such steps as identifying the pollutants which pose the greatest risks to or via the water environment. The priority under this directive is to identify and eliminate the sources of harmful emissions. A supplementary of WFD is Directive 2008/105/EC of the European Parliament and of the Council of 16 December 2008 on environmental quality standards in the field of water policy and Directive 2013/39/EU of the European Parliament and of the Council of 12 August 2013 amending Directives 2000/60/EC and 2008/105/EC as regards priority substances in the field of water policy which includes the list of 45 priority substances. Enactment in 2008 Directive 2008/56/EC of the European Parliament and of the Council of 17 June 2008 establishing a framework for community action in the field of marine environmental policy called the Marine Strategy Framework Directive (MSFD), widens the scope of the European Union (EU) legal framework to cover the marine environment for a new EU-integrated ecosystem policy for the protection of the water environment.

Requirements for the quality of wastewater discharged from the plant are included in Council Directive 91/271/EEC of 21 May 1991 concerning urban wastewater treatment. Directive determines the inter alia requirements for discharges from urban wastewater treatment plants, including emission limit values for these. Treated wastewater discharged from the WWTPs are characterized only by chemical and biochemical oxygen demand and total suspended solids. In the case that treated effluents from WWTPs are discharged to sensitive areas which are prone to eutrophication, provisions of the Directive require also the determination of total nitrogen and total phosphorus. Specifically, WWTPs effluents are controlled by a 'combined' approach of emission limit values, load reduction, and environmental quality standards, along with the restriction or phasing out of particularly priority and dangerous priority substances under these Directives (Corominas et al. [@CR11]).

Analyzing the provisions of Directives it should be noted that:The European Commission carries out a regular review of a list of priority substances in the field of water policy. The European Commission also prepares a list of observational material. Substances to be placed on the watch list are selected from among those for which the available information suggests that they may represent the significant risk to the aquatic environment or through, and for which monitoring data are insufficient (WFD [@CR91]). However, what has already been mentioned, for the relatively small number of organic pollutants in the environment changes are fully understood, and the majority of these impurities cannot be identified (HELCOM [@CR37]).Treated wastewater discharged from the WWTPs are characterized by total nitrogen/phosphorus, total suspended solids, and chemical/biochemical oxygen demand.Legal provisions do not take into account the interactions between pollutants (even those included in the list of priority substances) such as synergism, additivity, or antagonism.

Contaminants in treated wastewater {#Sec5}
----------------------------------

Conventional secondary processes (activated sludge and trickling filters) represent the most extensively used method of wastewater purification. However, these processes fail to remove large number of chemical compounds. For example, some pharmaceuticals such as paracetamol or ibuprofen are efficiently removed through conventional treatment methods (\> 99% and 72--100%, respectively) (Ratola et al. [@CR72]; Luo et al. [@CR57]), while others, such as sulfamethazine or carbamazepine are being removed from wastewater less effectively (13% and 7--23%, respectively) (Ratola et al. [@CR72]). As a result, compounds belonging to groups of pharmaceuticals, personal care products, surfactants, biocides, or flame retardants may be released to surface waters (rivers, lakes, or coastal waters) (Petrie et al. [@CR66]). Many pharmaceuticals may undergo various transformations in the environment, animal, or human body. Pharmaceuticals can be completely or partially metabolized in the organisms, what may lead to the unchanged parent drugs and the produced metabolites excretion via urine and/or feces (Ribeiro et al. [@CR74]). Particular interest is also aroused by transformation products that can be formed during water disinfection and wastewater treatment, as well as due to various processes occurring in natural waters such as biodegradation, photodegradation, hydrolysis (Nikolaou [@CR62]; Deeb et al. [@CR17]). What is more, compounds found in wastewater can degrade and/or react with other compounds in the environment re-emitting products of higher toxicity than the original compounds. The determination of the toxic effects of pharmaceuticals, their transformation products and mixtures in the environment, is a subject requiring urgent attention, and a great challenge for scientists. Moreover, they are present in trace concentrations (Nikolaou [@CR62]). Number of papers related to multiresidue analytical methodologies has increased over recent years; however, most of them are focused on target analysis methods (Kotowska et al. [@CR54]; Gurke et al. [@CR34]; García-Galán et al. [@CR25]; Knopp et al. [@CR50]; Roberts et al. [@CR76]; Madikizela and Chimuka [@CR59]; Petrie et al. [@CR67]; Wang et al. [@CR89]).

Potential risks of adverse effects caused by effluents from WWTPs to aquatic environments are influenced by volume of effluent, concentration of compounds in wastewater, the water flow rate of the receiving river, weather conditions, and probably other factors that affect dissipation through dilution and/or degradation. The compounds detected in effluents from sewage-treatment plants at concentrations above 1 µg/L and published in the period of 2015--2019 are listed in Table [1](#Tab1){ref-type="table"}. For our list, we established a limit of concentration recognized as environmentally relevant in prioritization of contaminants in wastewaters (Blum et al. [@CR8]; Gros et al. [@CR32]).Table 1The maximum concentrations of most often determined compounds in effluents from WWTPs, arranged in order of decreasing concentrationGroup of compoundsIdentified compoundsHighest concentration determined (µg/L)ReferencesAntidepressant agentsCitalopram840Cunha et al. ([@CR12])NanoparticlesNanoscale fragments containing 70-85% of carbon, low amounts of oxygen and heavy metals550 ± 130Hu et al. ([@CR40])AntiepilepticsGabapentin79.86Oliveira et al. ([@CR63])Analgesics/anti-inflammatoriesTramadol59.05Petrie et al. ([@CR66])Antiretroviral agentsLamivudine55.76 ± 5.48Ngumba ([@CR61])Antiretroviral agentsZidovudine37.14 ± 2.56Ngumba ([@CR61])Antiretroviral agentsEfavirenz34 ± 2.8Abafe et al. ([@CR1])H2-receptor antagonistsValsartan28.22Gurke et al. ([@CR34])Metabolites*N*-acetyl-4-aminoantipyrine25.03Evgenidou et al. ([@CR22])Industrial chemicals4-Methyl-1H-benzotriazole24.30Deeb et al. ([@CR17])Analgesics/anti-inflammatoriesDiclofenac23.50Madikizela and Chimuka. ([@CR59])Artificial sweetenerAcesulfame22.50Das et al. ([@CR13])Industrial chemical1H-benzotriazole22.10Deeb et al. ([@CR17])Artificial sweetenerSucralose18.80Tolouei et al. ([@CR85])Angiotensin receptor antagonistIrbesartan17.90Kårelid et al. ([@CR47])Contrast mediaIopromide17.90Qi et al. ([@CR70])Antiretroviral agentsDarunavir17 ± 0.55Abafe et al. ([@CR1])Contrast mediaIopamidol16.29Völker et al. ([@CR88])Anti-anxiety agentsBromazepam15.54Cunha et al. ([@CR12])Analgesics/anti-inflammatoriesNaproxen14.40Madikizela and Chimuka. ([@CR59])Analgesics/anti-inflammatoriesAcetaminophen11.73Petrie et al. ([@CR66])Contrast mediaDiatrizoate11.73Völker et al. ([@CR88])StimulantsCaffeine11.45Gros et al. ([@CR32])MetabolitesMetronidazole-OH11.34Evgenidou et al. ([@CR22])Contrast mediaIomeprol11.25Völker et al. ([@CR88])Antidiabetic drugsMetformin10.35Das et al. ([@CR13])DiureticsFurosemide9.96Papageorgiou et al. ([@CR64])Analgesics/anti-inflammatoriesNimesulide9.73Papageorgiou et al. ([@CR64])Metabolites4-Aminoantipyrine9.29Evgenidou et al. ([@CR22])Metabolites4-Methylaminoantipyrine9.25Evgenidou et al. ([@CR22])Analgesics/anti-inflammatoriesIbuprofen9.20Gros et al. ([@CR32])MetabolitesErythromycin-H~2~O7.84Evgenidou et al. ([@CR22])Anti-anxiety agentsOxazepam7.43Cunha et al. ([@CR12])Contrast mediaDiatrizoic acid7.03Ribbers et al. ([@CR73])Metabolites4′-Hydroxy diclofenac7.02García-Galán et al. ([@CR25])Beta-blockersMetoprolol5.76Gurke et al. ([@CR34])MetabolitesErythro/threo-hydrobupropion5.70Evgenidou et al. ([@CR22])Metaboliteso-desmethylvenlafaxine5.50Evgenidou et al. ([@CR22])Antidepressant agentsVenlafaxine5.50Roberts et al. ([@CR76])Analgesics/anti-inflammatoriesCodeine5.27Petrie et al. ([@CR66])Analgesics/anti-inflammatoriesKetoprofen5.25Oliveira et al. ([@CR63])AntibioticsCephalexin5.07Deeb et al. ([@CR17])Flame retardantsTri-(2-chloroisopropyl)phosphate4.90Gros et al. ([@CR32])Analgesics/anticonvulsantCarbamazepine4.61Deeb et al. ([@CR17])Flame retardantsTris-(2-butoxyethyl)phosphate4.60Gros et al. ([@CR32])Sunscreen Agent4-Benzophenone4.31Petrie et al. ([@CR66])Preservative and anti-infective agentTriclosan4.26Deeb et al. ([@CR17])Industrial chemicals2,4,7,9-Tetramethyl-5-decyne-4,7-diol4.20Blum et al. ([@CR8])AntiepilepticsLamotrigine4.12Oliveira et al. ([@CR63])DiureticsTheobromine4.01Oliveira et al. ([@CR63])Antiretroviral agentsLopinavir3.8 ± 0.35Abafe et al. ([@CR1])Metabolites10,11-Dihydro-trans-10,11-dihydroxy-carbamazepine3.60Evgenidou et al. ([@CR22])MetabolitesCarbamazepine-10,11-epoxide3.58Evgenidou et al. ([@CR22])Antiretroviral agentsRaltegravir3.5 ± 1.3Abafe et al. ([@CR1])DiureticsHydrochlorothiazide3.42Oliveira et al. ([@CR63])Transformation product (oxidation)Carboxy-Acyclovir3.40Knopp et al. ([@CR50])Beta-blockersSotalol3.33Roberts et al. ([@CR76])AntibioticsSulfamethoxazole3.25Oliveira et al. ([@CR63])BronchodilatorTheophylline3.17Petrie et al. ([@CR66])Lipid regulatorBezafibrate3.12Gros et al. ([@CR32])MetabolitesCotinine3.10Evgenidou et al.,[@CR22])Beta-blockersAtenolol2.87Deeb et al. ([@CR17])Angiotensin receptor antagonistTelmisartan2.75Gurke et al. ([@CR34])H2-receptor antagonistsCimetidine2.61Petrie et al. ([@CR66])MetabolitesMetoprolol acid2.51Evgenidou et al. ([@CR22])AntibioticsTrimethoprim2.40Deeb et al. ([@CR17])Flame retardantTris(2-butoxyethyl)phosphate2.40Blum et al. ([@CR8])AntibioticsPenicillin G2.22Deeb et al. ([@CR17])Industrial chemicalsTolyltriazole2.20Knopp et al. ([@CR50])AntibioticsLevofloxacin2.19Deeb et al. ([@CR17])AnalgesicsSalicylic acid2.18Evgenidou et al. ([@CR22])Angiotensin receptor antagonistCandesartan1.99Gurke et al. ([@CR34])Antiretroviral agentsNevirapine1.9 ± 0.68Abafe et al. ([@CR1])Metabolites10-Hydroxy-10,11-dihydrocarbamazepine1.90Evgenidou et al. ([@CR22])PsychoanalepticsDesmethylvenlafaxine1.87Oliveira et al. ([@CR63])MetabolitesGuanylurea1.86Evgenidou et al. ([@CR22])AntibioticsClarithromycin1.79Deeb et al. ([@CR17])Lipid-regulatorsSimvastatin1.74Papageorgiou et al. ([@CR64])Analgesics/anti-inflammatoriesAminopyrine1.68Deeb et al. ([@CR17])Anti-allergic agentsFexofenadine1.61Archer et al. ([@CR4])MetabolitesBenzoylecgonine1.60Petrie et al. ([@CR66])Metabolites4′-Hydroxy aceclofenac1.60Evgenidou et al. ([@CR22])Flame retardantTris(1-chloro-2-propyl)phosphate1.60Blum et al. ([@CR8])Antiretroviral agentsRitonavir1.50 ± 0.053Abafe et al. ([@CR1])AntibioticsNorfloxacin1.50Deeb et al. ([@CR17])PhytosterolsBeta-sitosterol1.50Wang et al. ([@CR89])Metabolites*O*-Desmethyltramadol1.47Archer et al. ([@CR4])Industrial chemicalsMethylindole1.42Deeb et al. ([@CR17])Beta-blockersLabetalol1.40Oliveira et al. ([@CR63])Solvents2-Butoxyethanol1.40Wang et al. ([@CR89])AntibioticsErythromycin1.39Petrie et al. ([@CR66])H2-receptor antagonistsRanitidine1.38Dasenaki and Thomaidis ([@CR14])HormonesProgesterone1.34Deeb et al. ([@CR17])MetabolitesCarboxy-ibuprofen1.27Evgenidou et al. ([@CR22])AntihistaminesCetirizine1.24Papageorgiou et al. ([@CR64])AntiepilepticsPregabalin1.24Gurke et al. ([@CR34])Flame retardant/plasticizerTris(2-chloroethyl)phosphate1.16Wang et al. ([@CR89])AntibioticsCiprofloxacin1.08Deeb et al. ([@CR17])Angiotensin receptor antagonistEprosartan1.04Gurke et al. ([@CR34])Analgesics/anti-inflammatoriesLidocaine1.00Oliveira et al. ([@CR63])

The compounds of the highest concentrations in treated effluents are antidepressant citalopram, antiepileptic gabapentin, anti-inflammatory tramadol and diclofenac, and antiretroviral drugs such as lamivudine, zidovudine, efavirenz, and darunavir. It is worth mentioning that one metabolite, *N*-acetyl-4-aminoantipyrine, a metabolite of dipyrone was found in effluent at concentration as high as 25.03 µg/L. Among other compounds with high concentrations also artificial sweeteners acesulfame and sucralose are detected at concentrations of 22.50 µg/L and 18.80 µg/L, respectively (Das et al. [@CR13]; Tolouei et al. [@CR85]). More than 95% of ingested sucralose is excreted in urine, \< 2% is degraded at wastewater treatment plants, and the rest is exported unaltered with effluent (Amy-Sagers et al. [@CR2]). Also X-ray contrast media such as iopamidol, iopromide, iomeprol are not effectively eliminated from the wastewater (Santos et al. [@CR80]).

Other micropollutants, which are detected in wastewater effluents, are nanoparticles (NP). Trace amounts of nanoparticles exist naturally in environment; however, recently, their incorporation in technology, medicine, and in many domestic consumer products, contribute to their presence in wastewaters and their inevitable release to aquatic ecosystems. The definition of NP stating that it is any material with at least one dimension in the range of 1--100 nm is very broad. Therefore, many substances such as metals (Ag, Zn, Ni, Fe, Cu); metal oxides (TiO~2~, Fe~3~O~4~, SiO~2~, CeO~2~, and Al~2~O~3~); non-metals (silica and quantum dots); forms of carbon (nanotubes, fullerene, graphene) exist in nanoscale (Madeła et al. [@CR58]). Therefore, even though concentration of nanoscale fragments noted in effluent was significantly high (550 ± 130 µg/L), the effluent content of specific nanoparticles is lower: 5.5 µg/L for Ag-NP, 19.1 µg/L for fullerene C~60~, 1.65 µg/L for fullerene C~70~, and 31.9021 µg/L for *N*-methylfulleropyrrolidine C~60~ (Farré et al. [@CR24]; Yang et al. [@CR93]).

Industrial chemicals, such as 1H-benzotriazole and 4-methyl-1H-benzotriazole, used in a wide range of commercial and industrial applications such as corrosion inhibitors, dishwasher detergents, and antifreezes are also among high-concentration micropollutants of 22.1 µg/L and 24.3 µg/L content, respectively (Deeb et al. [@CR17]).

Out of all the groups of compounds identified and determined in treated effluents, much attention is being paid to the presence of most commonly prescribed antibiotics (ciprofloxacin, doxycycline, norfloxacin, trimethoprim, and sulfamethoxazole) and analgesics/anti-inflammatory pharmaceuticals such as ibuprofen, naproxen, or diclofenac (Deblonde et al. [@CR16]). In addition, in treated wastewater, often triclosan, an ingredient in personal hygiene and household products such as soaps, toothpaste, mouthwash, deodorants, detergents, and disinfecting lotions is detected (Kotowska et al. [@CR54]).

Non-target analysis {#Sec6}
-------------------

Target analysis is focused on identification and quantification of certain compounds. However, quantification of target chemicals in the treated wastewater is insufficient for risk assessment, due to introduction of wastewater into the environment. The wastewater may contain many unknown substances. Screening of unknown organic compounds present in the treated wastewater allows for the identification of particularly hazardous compounds and can be useful for maintaining the suitable purity of surface water (Kotowska et al. [@CR53]). Most scientific research focuses on the determination of specific compounds. There are only few reports in literature on the identification of non-target contaminants in the treated sewage (Gómez et al. [@CR30]; Kotowska et al. [@CR53]; Hug et al. [@CR42]; Dsikowitzky et al. [@CR20]; Hrubik et al. [@CR39]; Blum et al. [@CR8]; Gros et al. [@CR32]). This is due to the fact that the analysis of these kinds of contaminants is complicated, time consuming, and represents a real challenge for environmental analysts. Non-target analysis allows for identification of both known and unknown chemicals. The analytical methods for the detection and quantification of non-target contaminants (in group of organic compounds) are generally based on separation methods, particularly gas chromatography (GC) or/and liquid chromatography (LC) coupled with a potential instrument for identification such as mass spectrometry (MS) (Gómez et al. [@CR30]). The choice of the applied method is associated with physicochemical properties of the target analytes. Liquid chromatography--high-resolution mass spectrometry (LC--HRMS) offers the possibility to detect hundreds of polar and non-polar compounds without pre-selection of analytes (Hug et al. [@CR42]).

In general for the analysis of pharmaceuticals in wastewater, it is appropriate to use GC; however, degradation products of some of those compounds may be thermolabile and decompose during GC analysis as it is in the case of carbamazepine and its degradation product iminostilbene (Gómez et al. [@CR30]). The compound's spectrum that is detectable with the use of GC--MS method is restricted to volatile, low-molecular weight non-polar to semi-polar organic substances (Dsikowitzky et al. [@CR20]). Additionally, the use of GC × GC allowed better separation of the analytes from interferences in complex samples without extensive sample preparation (Blum et al. [@CR8]). The disadvantage of GC--MS application is that it requires a time-consuming derivatization step, during which there are risks of analyte losses (Nikolaou [@CR62]). For identification of non-target compounds present in the treated wastewater a mass spectrometry scanning mode full-scan mode can be applied. Another method used, often for quantitative determination, is selected ion monitoring (SIM). The main advantage of the full-scan mode over the SIM mode is the possibility of simultaneous identification of various eluted compounds that could be of interest (Gómez et al. [@CR30]). A major disadvantage is that, generally, the full-scan method is less sensitive than SIM mode, although new generation equipment yields sufficient sensitivity (Gómez et al. [@CR30]). Considerable problems are also attributed to the analysis of the obtained chromatograms, as in non-target screening, in which often no initial information on the analytes is available, automated peak detection and spectra deconvolution algorithms are applied, which typically reveal several thousands of peaks in an individual wastewater sample (Hug et al. [@CR42]).

Environmental effects {#Sec7}
---------------------

Environmental risks posed by substances depend on their physical and chemical speciation and affinity for solid matter and water, which can have a significant impact on their bioavailability. Furthermore, the risk for living organisms is also dependent on the mobility of substances and their ability to be transferred up in the food chain. In the tissues of marine organisms contaminants can be accumulated or ingested from water or suspended matter. The result is that the pollutants concentration in the tissues of living organisms may be present at levels comparable to the concentrations in the environment or even higher (bioaccumulation). The wide variation in environmental conditions in different water areas can also affect bioavailability. Among these conditions: salinity, temperature, pH changes, or turbidity can be distinguished. In addition to the physicochemical properties, also the sensitivity of the species can affect the ability to bioaccumulate pollutants. Different species have different potential to bioaccumulate compounds, even when they are exposed to the same levels of specific pollutants. Even individuals of one species exposed to the same concentration of contaminants in for similar period of time may not accumulate the substance at the same rate. It is associated with other factors such as age, sex, size, and physiological state of the organism (Garnaga [@CR26]).

Information on the concentration levels of chemicals in treated effluents is insufficient to assess the risk to aquatic ecosystems. The results of chemical analysis of target and non-target compounds provide only some information about the potential hazard to humans and the environment. In addition, analysis of non-target compounds presents many difficulties for the analyst. Due to the fact that in treated sewage a complex mixture of compounds is present and also degradation and transformation products of these compounds are occurring, it is difficult to predict the effects of this type of bottom-up approach, based on criteria for individual chemicals (Fang et al. [@CR23]). Many compounds present in treated effluents exhibit toxic properties. Therefore, the main detrimental effects of organic micropollutants are attributed to their potential acute toxicity or sub-lethal effects on the biota. Ecotoxicological studies seem to be an excellent tool for assessing the hazards arising from the presence of harmful compounds in the treated wastewater. The ecotest results reflect the actual threat to organisms occurring in certain ecosystems. What is more, they are less time consuming and do not require highly specialized analytical equipment and staff.

Ecotoxicity tests are performed on a biological sample, i.e., a representative population of a given species of organism, which is (or is not) a subject to some change/modification after exposure to the particular pollutant for a certain time. In ecotoxicological studies various bioassays, based on aquatic organisms, are used such as bacteria, algae, macrophytes, molluscs, crustacean, and fish. It is recommended to perform several tests incorporating various species that represent different trophic levels. The test result is based on the determination of the dose or concentration of the chemical substance inducing the specific effect on the indicator organism (e.g., LC~50~---lethal concentration which causes death in 50% individuals in the population, EC~50~---effect concentration which causes a measurable effect in 50% of individuals in population, IC~50~---inhibition concentration that causes growth suppression of 50% of individuals in population). In Table [2](#Tab2){ref-type="table"}, toxicity of the compounds, which were identified at the highest concentration levels in the treated wastewater (see Table [1](#Tab1){ref-type="table"}), towards the selected indicator organisms is given. This group of compounds is mainly dominated by pharmaceuticals.Table 2Toxicity parameters of the compounds which were identified at the highest concentration levels in the treated wastewaterName of the compoundParameter measured, duration of the testToxicity (mg/L)SpeciesAdditional informationReferencesCitalopramEC~50~, 72 h3.300*Pseudokirchneriella subcapitata*Minguez et al. ([@CR60])EC~50~, 48 h1.600*Pseudokirchneriella subcapitata*Growth inhibitionCunha et al. ([@CR12])EC~50~, 72 h0.505*Skeletonema marinoi*Minguez et al. ([@CR60])EC~50~3.9*Ceriodaphnia dubia*Cunha et al. ([@CR12])LOEC, 8 days4.0*Ceriodaphnia dubia*ReproductionEC~50~30.14*Daphnia similis*EC~50~, 48 h30.14*Daphnia magna*Minguez et al. ([@CR60])EC~50~, 24 h22.81*Daphnia magna*Yang et al. ([@CR94])EC~50~, 48 h7.44*Daphnia magna*EC~50~, 48 h\> 100*Artemia salina*Minguez et al. ([@CR60])LOEC0.000405*Leptoxis carinata*Cunha et al. ([@CR12])GabapentinLD~50~, 96 h50*Oncorhynchus mykiss*Pfizer ([@CR68])EC~50~, 24 h\> 500*Daphnia magna*EC~50~, 48 h\> 100*Daphnia magna*Minguez et al. ([@CR60])EC~50~, 72 h\> 100*Pseudokirchneriella subcapitata*EC~50~, 48 h\> 100*Artemia salina*EC~50~, 72 h\>100*Skeletonema marinoi*TramadolLC~50~, \< 96 h130Unspecified fishTramadol HClSanderson and Thomsen ([@CR79])EC~50~, 48 h73*Daphnia spp.*Tramadol HClEC~50~, 24 h170*Daphnia magna*Le et al. ([@CR56])EC~50~\> 4000*Pseudomonas putida*Tramadol HClBergheim et al. ([@CR7])LamivudineEC~50~, 72 h49.06*Pseudokirchneriella subcapitata*In pharmaceutical product, Kivexa with formoterol and abacavirGuo et al. ([@CR33])EC~50~, 72 h\> 96.9*Pseudokirchneriella subcapitata*In pharmaceutical product ZeffixEC~50~, 72 h96.9*Pseudokirchneriella subcapitata*In pharmaceutical product EpivirEfavirenzEC~50~, 72 h\>0.012*Pseudokirchneriella subcapitata*In pharmaceutical product StocrinGuo et al. ([@CR33])EC~50~0.012--96.9Green algaeEC~10~, 12 days\>0.76*Microcystis aeruginosa*In pharmaceutical product Stocrin96 h1.03 × 10^−5^*Oreochromis mossambicus*Liver damage, histology-based assessmentRobson et al. ([@CR77])ValsartanNOEC, 72 h85*Desmodesmus subspicatus*Perrodin and Orias ([@CR65])LC~50~,96 h\> 100*Salmo gairdneri* (*Oncorhynchus mykiss*)Bayer et al. ([@CR6])OncorhynchusEC~50~, 48 h\> 580*Daphnia magna*EC~50~, 48 h\> 100*Daphnia magna*Minguez et al. ([@CR60])EC~50~, 72 h\> 100*Pseudokirchneriella subcapitata*EC~50~, 48 h\> 100*Artemia salinaN*-acetyl-4-aminoantipyrineLC~20~10*Daphnia magna*Gómez et al. ([@CR29])4-Methyl-1H-benzotriazoleNOEC\> 15*Oncorhynchus mykiss* (epithelial cell lines)In mixture (1:1) with 5-methyl-1H-benzotriazoleZeng et al. ([@CR95])EC~50~, 15 min21*Vibrio fischeri*Pillard et al. ([@CR69])LC~50~, 48 h118*Ceriodaphnia dubia*LC~50~, 96 h63*Pimephales promelas*DiclofenacEC~50~1950*Raoultella* sp, strain DD4Domaradzka et al. ([@CR18])EC~50~, 15 min14.31*Vibrio fischeri*Sodium saltDe García et al. ([@CR15])EC~50~416.67*Staphylococcus warneri*Domaradzka et al. ([@CR18])MTC (microbial toxic concentration)\> 1300*Pseudomonas aurantiacaSerratia rubidaea*EC~50~782.11*Sorghum bicolor*Sodium saltWieczerzak et al. ([@CR92])EC~50~, 7 days7.5*Lemna minor*Total frond areaCleuvers ([@CR10])EC~50~, 3 days72*Desmodesmus subspicatus*Sodium saltEC~50~, 48 h68*Daphnia magna*Sodium salt,AcesulfameNOEC, 48 h\> 1000*Daphnia magna*Stolte et al. ([@CR82])NOEC, 7 days\> 1000*Lemna minor*NOEC, 24 h\> 1000*Scenedesmus vacuolatus*1H-benzotriazoleEC~10~, 72 h1.18*Desmodesmus subspicatus*Seeland et al. ([@CR81])EC~50~, 72 h231*Scenedesmus subspicatus*GrowthCantwell et al. ([@CR9])EC~50~, 72 h102*Scenedesmus subspicatus*BiomassEC~50~, 15 min41.65*Vibrio fischeri*LuminescenceLC~50~, 48 h107*Daphnia magna*ImmobilizationSeeland et al. ([@CR81])EC~50~, 21 days25.9-76.9*Daphnia magna*ReproductionCantwell et al. ([@CR9])LC~50~, 48 h102*Ceriodaphnia dubia*MortalityPillard et al. ([@CR69])EC~50~, 48 h15.8*Daphnia galeata*ImmobilizationSeeland et al. ([@CR81])LC~50~, 96 h65*Pimephales promelas*Pillard et al. ([@CR69])LC~50~, 96 h25*Pimephales promelas*Mortality, staticCantwell et al. ([@CR9])LC~50~, 48 h25.7*Pimephales promelas*Mortality, staticLC~50~, 48 h27.5*Lepomis macrochirus*Mortality, juvenile, staticCantwell et al. ([@CR9])LC~50~, 96 h25*Lepomis macrochirus*Mortality, juvenile, staticEC10,7 days3.94*Lemna minor*Seeland et al. ([@CR81])EC~50~, 16 days8.3*Chlorella sorokiniana*GrowthGatidou et al. ([@CR27])SucraloseNOEC, 21 days1800*Daphnia magna*Huggett and Stoddard ([@CR43])EC~50~/LC~50~, 28 days\> 93*Mysid shrimp*EC~50~/LC~50~\> 1800*Daphnia magna*Tollefsen et al. ([@CR84])EC~50~/LC~50~, 96 h\> 1800*Green algae*NOEC, 7 days114*Lemna gibba*NOEC, 28 days93*Americamysis bahia*Huggett and Stoddard ([@CR43])IrbesartanEC~50~, 96 h460*Pseudokirchneriella subcapitata*In pharmaceutical product AprovelGuo et al. ([@CR33])EC~50~, 48 h\> 100*Daphnia magna*Minguez et al. ([@CR60])EC~50~, 72 h\> 100*Pseudokirchneriella subcapitata*EC~50~, 48 h\> 100*Artemia salina*IopromideEC~50~, 72 h10 000*Pseudokirchneriella subcapitata*In pharmaceutical product UltravistGuo et al. ([@CR33])EC~50~, 48 h\> 1000*Daphnia magna*Santos et al. ([@CR80])NOEC, 28 days\> 100*Danio rerio*DarunavirEC~50~43-100Green algaeGuo et al. ([@CR33])EC~50~, 72 h\> 43*Pseudokirchneriella subcapitata*In pharmaceutical product PrezistaBromazepamLOEC1.5*Danio rerio*Gebauer et al. ([@CR28])LOEC/21-23 days0.0001*Daphnia magna*Rivetti et al. ([@CR75])LOEC 48 h0.0001*Daphnia magna*NaproxenEC~50~, 48 h174*Daphnia magna*Naproxen-sodiumCleuvers ([@CR10])EC~50~, 48 h43.64*Ceriodaphnia dubia*Naproxen-sodiumIsidori et al. ([@CR45])EC~50~, 48 h66.37*Ceriodaphnia dubia*LC~50~, 24 h43.54*Thamnocephalus platyurus*Naproxen-sodiumLC~50~, 24 h84.09*Thamnocephalus platyurus*EC~50~, 96 h2.68*Hydra attenuata*Quinn et al. ([@CR71])LC~50~, 24 h54.64*Brachionus calyciflorus*Naproxen-sodiumIsidori et al. ([@CR45])EC~50~, 7 days24.2*Lemna minor*Naproxen-sodiumCleuvers ([@CR10])EC~50~, 96 h3.7*Pseudokirchneriella subcapitata*Harada et al. ([@CR36])IC~50~, 96 h39.31*Pseudokirchneriella subcapitata*Naproxen-sodiumIsidori et al. ([@CR45])EC~50~, 3 days\> 320*Desmodesmus subspicatus*Naproxen-sodiumCleuvers ([@CR10])EC~50~, 15 min18.5*Vibrio fischeri*Harada et al. ([@CR36])EC~50~, 15 min17.92*Vibrio fischeri*De García et al. ([@CR15])AcetaminophenEC~50~, 48 h\> 160*Oryzias latipes*Kim et al. ([@CR48])EC~50~, 96 h\> 160*Oryzias latipes*LC~50~, 96 h26.6*Daphnia magna*LC~50~, 48 h30.1*Daphnia magna*EC~50~, 48 h34.99*Daphnia magna*Minguez et al. ([@CR60])EC~50~, 5 min549.7*Vibrio fischeri*Kim et al. ([@CR48])EC~50~, 15 min657.5*Vibrio fischeri*EC~50~, 15 min363.30*Vibrio fischeri*De García et al. ([@CR15])EC~50~, 72 h\> 100*Pseudokirchneriella subcapitata*Minguez et al. ([@CR60])EC~50~, 48 h\> 100*Artemia salina*DiatrizoateNOEC613.92--0.61392 × 10^−5^ (10^−3^--10^−11^ M)*Tetrahymena pyriformis*Na-diatrizoateLáng and Kőhidai ([@CR100])NOEC613.92 (0.001 M)CiliatePopulation growthPerrodin and Orias ([@CR65])CaffeineEC~50~290.2*Desmodesmus subspicatus*Population growthKobetičová et al. ([@CR51])IC~50~265*Sinapis alba*Root lengthMetronidazole-OHIC~50~, 30 min\> 100*aerobic bacteria*MetronidazoleKümmerer et al. ([@CR55])IC~50~, 20 h\> 100*aerobic bacteria*MetronidazoleEC~50~243*Vibrio fischeri*MetronidazoleKołodziejska et al. ([@CR52])EC~50~\> 64 000*Pseudomonas putida*MetronidazoleKümmerer et al. ([@CR55])MetforminEC~50~, 48 h64*Daphnia magna*Cleuvers ([@CR10])EC~50~, 3 days\> 320*Desmodesmus subspicatus*EC~50~, 7 days110*Lemna minor*

The highest toxicity to *Pseudokirchneriella subcapitata* microalgae was noted for citalopram and naproxen, while for gabapentin, valsartan, irbesartan, and acetaminophen it was the lowest. High sensitivity to naproxen and its compounds also show *Vibrio fischeri* bacteria, *Hydra attenuate,* and *Lemna minor.* A source of high toxicity to *Lemna minor* was also diclofenac and benzotriazole. However, acesulfame is not toxic to *Lemna minor*.

Acetaminophen exhibits high toxicity to *Daphnia magna*, whereas its toxicity to the bacteria *Vibrio fischeri* is low. In turn, gabapentin manifests low toxicity with respect to all the examined indicator organisms. *Vibrio fischeri* bacteria are also sensitive for diclofenac but responsive to metronidazole (see Table [2](#Tab2){ref-type="table"}). Studies reported that X-ray contrast media (i.e., iopromide, iopamidol) did not pose risk to aquatic organisms at environmentally relevant concentrations; however, data on combined toxic effects between X-ray contrast media and other substances present in environment are still scarce (Haiß and Kümmerer [@CR35]; Tran et al. [@CR86]).

Many of the compounds identified in wastewater have the potential to disrupt endocrine processes. Endocrine-disrupting chemicals (EDCs) are substances naturally or anthropogenically occurring in the environment. According to the definition, adopted by World Health Organization (WHO), they are exogenous compounds or mixtures with properties to change the function of the endocrine system, which will result in negative consequences on the organism, its progeny, or subpopulations. These compounds belong to different chemical families, and are able to interfere with the hormonal system of exposed organisms by mimicking or counteracting natural hormones (Huerta et al. [@CR41]). It has been estimated that from hundreds of thousands of presently produced compounds around 1000 of them may have endocrine-disrupting properties (Gore et al. [@CR31]). Those compounds include mainly polychlorinated biphenyls (PCBs), bisphenol A, phthalates, pesticides, some pharmaceuticals, brominated flame retardants, and organic tin compounds (Kima et al. [@CR49]). The standard method for biological treatment of wastewater used in a typical wastewater treatment results in only partial removal of the compounds from the group of EDCs, mainly of polar nature (Välitalo et al. [@CR87]). EDCs are detected both in surface and ground waters. This phenomenon is alarming due to the fact that those compounds, when released into the water, may adversely affect living organisms, even if they occur at low levels (Kima et al. [@CR49]). There are many literature reports which indicate that EDCs can cause adverse effects on the aquatic environment even at low concentrations. For example, studies have shown that Zebrafish were sensitive to estradiol at a very low concentration of 0.2 ng/L (Westerlund et al. [@CR90]). The EDCs compounds identified in treated effluents include phthalate compounds such as bis (2-ethylhexyl) benzene-1,2-dicarboxylate (DEHP) and benzyl butyl benzene-1,2-dicarboxylate (BBP) and phenols such as 4-*tert*-octylphenol and bisphenol A (BPA). These compounds are included at the European Commission priority lists of 66 endocrine active substances for which clear evidence of endocrine-disrupting activity is confirmed (Category I) (EC [@CR21]).

An alternative for classical analytical methods for the determination of endocrine active substances are endocrine tests. These bioassays can thus be used to determine total estrogenic activities in (extracts of) environmental samples, without the necessity of knowing all compounds present that contribute to the activity (Houtman et al. [@CR38]). The most commonly used tests include reporter gene assays such as the yeast estrogen/androgen screen (YES/YAS), which allows identification of both, the activation (agonist) or inhibiting (antagonist) properties in samples of wastewater or estrogen receptor-mediated chemical-activated luciferase gene expression (ER-CALUX^®^) assay (Houtman et al. [@CR38]).

Exposure to chemical substances may cause damage of the genetic material of the organisms. Genotoxic compounds acting directly or indirectly on the body have the potential for altering the organism's genetic code. In addition, such compounds can induce changes not only within one generation. Effects of their action can be observed over an extended period of time, across the whole population. Therefore, it is important to carry out genotoxicity studies, especially in the case if a particular ecosystem is exposed to the constant supply of pollutants.

EDCs in wastewater effluents may be leached from microplastics (Anderson et al. [@CR3]). Microplastics pollution is a high and increasing concern in European Union (SAM [@CR78]). The term microplastics refers to the group of organic polymers derived from various petroleum compounds with the upper size limit of 5 mm. Studies indicated that wastewater treatment plants (WWTPs) play an important role in releasing microplastics to the environment. The growing concerns about microplastics presence in wastewater effluents and subsequently in marine environment have been attributed to their ubiquity, long residence times accompanied by difficult removing, possibility of being assimilated by living organisms, and thus entering trophic levels as well as easiness to undergo numerous transformations during wastewater treatment process (Anderson et al. [@CR3]; Sun et al. [@CR83]). WWTP are not designed to fully remove microplastics, and its removal depends on the treatment process applied; however, in most cases it exceeds 80--90%. An average microplastics concentrations reviewed in literature is in the range of 0--447 particles/L (Sun et al. [@CR83]).

Conclusion {#Sec8}
==========

Over the last years, the issue of water quality has gained strategic importance, both in the European Union and internationally. The challenge of the present day is to protect effectively aquatic ecosystems, to preserve their good condition and to reduce negative impacts on human health. The purpose of wastewater treatment plant is to remove compounds that may have adverse effects on the environment and on human health, but as the research shows the processes used in wastewater treatment are insufficient. As a result, compounds potentially hazardous may enter the surface waters. Legislation aimed at eliminating/reducing emissions to the environment are restricted to a narrow spectrum of chemicals. Most of the compounds remain beyond the legal norms.

As we have shown in our paper, the interest in the presence of micropollutants in wastewater has been reflected in the research carried out. Studies on the quality evaluation of treated effluents are carried out in a number of research centers around the world. They mainly focus on the determination of the target compounds and relate to pharmaceuticals such as analgesic/anti-inflammatories or antibiotics. Carried out literature review on the highest concentrations of contaminants in treated effluents indicates that they are observed for analgesic/anti-inflammatory drugs, i.e., diclofenac, tramadol naproxen, antiretroviral agents, industrial chemicals, or contrast media. These compounds occur at levels of several tens of μg/L. Although the number of studies on the determination of target pollutants in the treated wastewater is constantly increasing, there are few reports in literature on the identification of non-target compounds present in the treated wastewater. This is primarily due to the fact that such research is time consuming, requires a variety of analytical techniques, often complex or costly and sophisticated equipment. The classical methodology for assessing the environmental impact of xenobiotics, which is required by legislation, is based on the use of chemical analysis techniques, which allow to determine the concentrations of pollutants in environmental samples. However, the thus obtained results do not adequately reflect the risks to ecosystems and subsequently humans. On the basis of chemical analysis, the possible interactions between toxic substances and their mixture effects on living organisms cannot be determined. Therefore, the methodology for assessing the quality of treated wastewater should include, in addition to chemical analyses, ecotoxicological, genotoxic/mutagenic, or endocrine activity studies. In this way, comprehensive information on the hazard arising from the presence of all known and unknown hazardous substances in the treated wastewater is needed. Moreover, it should be noted that during wastewater treatment various by-products, of unknown properties and toxicity may be formed. Therefore, when developing new, more effective methods of wastewater treatment, it is necessary to evaluate the toxicity of the resulting products. What is more, the indicator organisms selected for ecotoxicity evaluation should be from different trophic levels as various organisms may exhibit a diverse sensitivity to the compounds, e.g., naproxen is highly toxic to *Hydra attenuata* and its toxicity to *Daphnia magna* is low. Researchers from the Institute for Inland Water Management and Water Treatment (RIZA) have already mentioned the need for a comprehensive assessment of waste water quality in the 1990s. A method for whole-effluent assessment contained a series of tests to make (potential) effects visible, focusing on the following five parameters: acute and chronic toxicity, bioaccumulation, mutagenicity, and persistence.

The problem of occurrence of potentially hazardous compounds in wastewater and surface waters to which wastewater is being discharged has been observed in many countries. The first country in which legal regulations were issued, mandating the implementation of the subsequent stage of sewage treatment intended to remove the micropollutants is Switzerland. Similar actions have been taken in Germany. Therefore, it seems that the introduction of wastewater treatment technology of micropollutants removal in other European countries is only a matter of time.
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